We are live on ! Find out more
SC

Stralem & Co Portfolio holdings

AUM $157M
1-Year Est. Return 4.29%
This Fund
S&P 500
This Quarter Est. Return
+2.83%
1 Year Est. Return
+4.29%
3 Year Est. Return
+25.48%
5 Year Est. Return
+55.56%
10 Year Est. Return
–
AUM
$855M
AUM Growth
+$699K
Cap. Flow
-$18.9M
Cap. Flow %
-2.2%
Top 10 Hldgs %
32.94%
Holding
50
New
2
Increased
12
Reduced
29
Closed
2

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$26M
2
XOM icon
ExxonMobil
XOM
+$1.32M
3
NVDA icon
NVIDIA
NVDA
+$1.02M
4
EOG icon
EOG Resources
EOG
+$916K
5
CVX icon
Chevron
CVX
+$748K

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$21.1M
2
ADBE icon
Adobe
ADBE
+$5.7M
3
META icon
Meta Platforms (Facebook)
META
+$2.94M
4
UNH icon
UnitedHealth
UNH
+$2.94M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$2.56M

Sector Composition

Rank Sector Weight
1 Healthcare 23.61%
2 Technology 13.35%
3 Communication Services 12.06%
4 Consumer Staples 9.26%
5 Utilities 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SLB icon
26
SLB Ltd
SLB
$78.1B
$19.5M 2.28%
295,760
+1,750
+0.6% +$125K
CB icon
27
Chubb
CB
$132B
$18.9M 2.21%
130,195
-4,250
-3% -$598K
ABT icon
28
Abbott
ABT
$192B
$18.4M 2.15%
377,755
+400
+0.1% +$18.1K
TMO icon
29
Thermo Fisher Scientific
TMO
$223B
$18.3M 2.14%
104,695
-4,070
-4% -$684K
JNJ icon
30
Johnson & Johnson
JNJ
$629B
$18.2M 2.13%
137,570
-4,610
-3% -$588K
AMGN icon
31
Amgen
AMGN
$225B
$17.7M 2.07%
102,615
+600
+0.6% +$97.6K
CELG
32
DELISTED
Celgene Corp
CELG
$17.6M 2.06%
135,405
-3,510
-3% -$430K
EOG icon
33
EOG Resources
EOG
$75.1B
$17.4M 2.03%
192,130
+9,950
+5% +$916K
CVX icon
34
Chevron
CVX
$386B
$16.8M 1.96%
160,905
+7,060
+5% +$748K
XOM icon
35
ExxonMobil
XOM
$657B
$16.7M 1.95%
206,520
+16,150
+8% +$1.32M
BMY icon
36
Bristol-Myers Squibb
BMY
$130B
$2.81M 0.33%
50,400
+5,300
+12% +$288K
KO icon
37
Coca-Cola
KO
$373B
$1.53M 0.18%
34,200
-3,900
-10% -$172K
NVDA icon
38
NVIDIA
NVDA
$5.43T
$1.16M 0.14%
+320,000
New +$1.02M
FE icon
39
FirstEnergy
FE
$27.2B
$1.08M 0.13%
37,100
+4,600
+14% +$137K
ADP icon
40
Automatic Data Processing
ADP
$107B
$1.08M 0.13%
10,500
-2,400
-19% -$243K
A icon
41
Agilent Technologies
A
$41.9B
$1.06M 0.12%
17,900
– –
LLY icon
42
Eli Lilly
LLY
$1.09T
$1.04M 0.12%
12,600
– –
IFF icon
43
International Flavors & Fragrances
IFF
$21.4B
$1.01M 0.12%
7,500
+1,000
+15% +$136K
CL icon
44
Colgate-Palmolive
CL
$73.6B
$941K 0.11%
12,700
– –
AAPL icon
45
Apple
AAPL
$4.41T
$922K 0.11%
25,600
-7,200
-22% -$266K
GILD icon
46
Gilead Sciences
GILD
$168B
$906K 0.11%
12,800
+3,200
+33% +$213K
COST icon
47
Costco
COST
$421B
$896K 0.1%
5,600
– –
ZBH icon
48
Zimmer Biomet
ZBH
$18.7B
$860K 0.1%
6,901
– –
ADM icon
49
Archer Daniels Midland
ADM
$38.4B
– –
-4,700
Closed -$216K
CVS icon
50
CVS Health
CVS
$121B
– –
-268,170
Closed -$21.1M
1
2

Similar funds

LI
Leap Investments Chicago, Illinois $152M AUM 3.6% 1-Year Est. Return
BC
Blackstart Capital New York $151M AUM 14.01% 1-Year Est. Return
JT
Jump Trading Chicago, Illinois $150M AUM 17.61% 1-Year Est. Return
SCM
Stellar Capital Management Phoenix, Arizona $147M AUM 5.91% 1-Year Est. Return
HF
Hellman & Friedman San Francisco, California $169M AUM
SMFS
Squar Milner Financial Services Irvine, California $176M AUM 10.56% 1-Year Est. Return
CCM
Cloverdale Capital Management Dallas, Texas $135M AUM 13.89% 1-Year Est. Return
CCM
Castine Capital Management Boston, Massachusetts $129M AUM 23.45% 1-Year Est. Return

Stralem & Co's Q2 2017 Portfolio in Review

As of Q2 2017, Stralem & Co held 50 positions worth $855M, up 0.08% from $855M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Stralem & Co's Q2 2017 filing shows 2 new, 12 increased, 29 reduced and 2 closed positions. Its largest new stake was Broadcom: 1,121,200 shares worth $26.1M. The largest sale was CVS Health, an estimated $21.1M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 25% a quarter earlier, followed by Technology and Communication Services.

  • Stralem & Co's largest Q2 2017 buy was Broadcom: 1,121,200 shares worth $26.1M.
  • Stralem & Co added most to ExxonMobil in Q2 2017, an estimated $1.32M increase.
  • Stralem & Co's biggest Q2 2017 reduction was Adobe, cutting an estimated $5.7M.
  • Stralem & Co fully exited CVS Health in Q2 2017, selling an estimated $21.1M.
  • Stralem & Co's ten largest holdings make up 33% of its $855M portfolio in Q2 2017.
  • Stralem & Co opened 2 new positions and closed 2 in Q2 2017.
  • Stralem & Co's portfolio value rose 0.08% quarter-over-quarter to $855M.

Based on Stralem & Co's 13F filing for Q2 2017, filed 19 Jul 2017.